Pharma BD Deal Intelligence
DongWha Pharm / Quantum Genomics
2020 · Licensing/Option · $18M · Pending
This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2025 at the earliest for this deal, once/if it closes.
Key facts
- Announced Dec 02, 2020
- Deal value $18M
- Deal type Licensing/Option
Related deals
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
More: 2020 deals